Effect of atorvastatin on non-cholesterol sterols in patients with type 2 diabetes mellitus and cardiovascular disease (original) (raw)
Comparative efficacy study of atorvastatin vs. simvastatin, pravastatin, lovastatin and placebo in type 2 diabetic patients with hypercholesterolaemia
Salvatore Turco
Diabetes, Obesity and Metabolism, 2000
View PDFchevron_right
Article title: Directions and Essential Experimental Findings of Statin Treatment in Diabetic Patients
Gabriela Balan, Costinela Georgescu, Cristian C . Gavat
ScienceOpen Preprints, 2024
View PDFchevron_right
Esterification of HDL-cholesterol is Decreased in Diabetes Mellitus and CAD and Enhanced Following Treatment with Statins
Mehdi Rasouli
Medical archives (Sarajevo, Bosnia and Herzegovina), 2018
View PDFchevron_right
Directions and Essential Experimental Findings of Statin Treatment in Diabetic Patients
Ana Pelin, Cristian C . Gavat
ScienceOpen.com, 2024
View PDFchevron_right
Statin therapy for primary prevention and its effect on new-onset diabetes, mace and all-cause mortality - A real-world population cohort study
Morton Leibowitz
Atherosclerosis, 2018
View PDFchevron_right
Effect of atorvastatin on postprandial lipoprotein metabolism in hypertriglyceridemic patients
Ron Barrett
The Journal of Lipid Research, 2003
View PDFchevron_right
Targets of Statin Therapy: LDL Cholesterol, Non-HDL Cholesterol, and Apolipoprotein B in Type 2 Diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS)
Helen Colhoun, M. Szarek
Clinical Chemistry, 2009
View PDFchevron_right
Particularities of Statin Therapy in Diabetic Patients
Cristian C . Gavat
REVISTA DE CHIMIE REV.CHIM.(Bucharest) -Original Edition:, 2017
View PDFchevron_right
Effects of Increasing Doses of Atorvastatin on the Atherogenic Lipid Subclasses Commonly Associated With Hypertriglyceridemia
Don Luo
The American Journal of Cardiology, 2007
View PDFchevron_right
Effect of a statin on hepatic apolipoprotein B-100 secretion and plasma campesterol levels in the metabolic syndrome
Gilbert Thompson
International Journal of Obesity, 2003
View PDFchevron_right
Lathosterol and other noncholesterol sterols during treatment of hypercholesterolemia with lovastatin alone and with cholestyramine or guar gum
Blanka Míková
Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
View PDFchevron_right
Prolonged inhibition of cholesterol synthesis explains the efficacy of atorvastatin
Loukianos Rallidis
View PDFchevron_right
Atorvastatin Causes Insulin Resistance and Increases Ambient Glycemia in Hypercholesterolemic Patients
Michael J Quon
Journal of the American College of Cardiology, 2010
View PDFchevron_right
Rosuvastatin and atorvastatin: comparative effects on glucose metabolism in non-diabetic patients with dyslipidaemia
ahmed abbas
Clinical medicine insights. Endocrinology and diabetes, 2012
View PDFchevron_right
Cholesterol metabolism and non-cholesterol sterol distribution in lipoproteins of type 1 diabetes: The effect of improved glycemic control
Jussi Pihlajamäki
Atherosclerosis, 2007
View PDFchevron_right
Comparative study of low doses of rosuvastatin and atorvastatin on lipid and glycemic control in patients with metabolic syndrome and hypercholesterolemia
Ji-yong Choi
The Korean journal of internal medicine, 2010
View PDFchevron_right
Effects of Maximal Doses of Atorvastatin Versus Rosuvastatin on Small Dense Low-Density Lipoprotein Cholesterol Levels
Bela Asztalos
The American Journal of Cardiology, 2008
View PDFchevron_right
Effects of Atorvastatin and Rosuvastatin on glycemic parameters of dyslipidemic patients: A prospective study
Jameel Ahmad
Asian Journal of Pharmacy and Pharmacology, 2020
View PDFchevron_right
The Comparison of Simvastatin and Atorvastatin Efficacy in Lowering Lipid Profile and Apolipoprotein-B of Diabetic Dyslipidemia Patient
Sony Wibisono
2013
View PDFchevron_right
Efficacy of Atorvastatin and Gemfibrozil, Alone and in Low Dose Combination, in the Treatment of Diabetic Dyslipidemia
Jordi ordonez-llanos
The Journal of Clinical Endocrinology & Metabolism, 2003
View PDFchevron_right
Plasma pre β-HDL formation is decreased by atorvastatin treatment in type 2 diabetes mellitus: Role of phospholipid transfer protein
Arie Van Tol
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2009
View PDFchevron_right
Effects of atorvastatin 10 mg/d on insulin resistance: A 12-week, open-label study in hyperlipidemic patients
Oguz Yavuzgil
Current Therapeutic Research, 2006
View PDFchevron_right
Beneficial effects of atorvastatin on sd LDL and LDL phenotype B in statin-naive patients and patients previously treated with simvastatin or pravastatin
J. Ducobu, Yvon Carpentier
International Journal of Cardiology, 2005
View PDFchevron_right
Paradoxical decrease in HDL-cholesterol and apolipoprotein A1 with simvastatin and atorvastatin in a patient with type 2 diabetes
Sud Ramachandran
Annals of Clinical Biochemistry, 2010
View PDFchevron_right
To compare rosuvastatin with atorvastatin in terms of mean change in LDL-C in patient of diabetes mellitus
Zain Masood
The Professional Medical Journal, 2020
View PDFchevron_right
Efficacy and safety of atorvastatin in hyperlipidemic, type 2 diabetic patients. A 34-week, multicenter, open-label study
Francisco Gómez-pérez
Atherosclerosis, 2000
View PDFchevron_right
Comparative Study of Efficacy of Atorvastatin 40 Mg Daily Rosuvastatin 20 Mg Daily And Rosuvastatin 20 Mg Alternate Day Day ,Among Diabetic Patients.A Study Of 300 Patients
Mukul Misra
IOSR Journal of Dental and Medical Sciences, 2017
View PDFchevron_right